Patient function improved as measured by the health assessment questionnaire - Disability index (HAQ-DI), following daily subcutaneous (SC) injections of kineret; (Anakinra-recombinant interleukin-1 receptor antagonist) in a standard practice populatio Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

publication date

  • July 1, 2003